Benjamin J. Zeskind Immuneering Corp (IMRX) insider trading activity

IMRX Quotes by TradingView

Benjamin J. Zeskind is PRESIDENT AND CEO of Immuneering Corp. Currently has a direct ownership of 2.31 Million shares of IMRX, which is worth approximately $8 Million. The most recent transaction as insider was on Jul 02, 2025, when has been sold 7,015 shares (Class A Common Stock) at a price of $3.53 per share, resulting in proceeds of $24,762. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.31M
1.36% 3M change
1.36% 12M change
Total Value Held $8 Million

Benjamin J. Zeskind Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 02 2025
BUY
Open market or private purchase
$24,762 $3.53 p/Share
7,015 Added 0.3%
2,312,852 Class A Common Stock
Jul 01 2025
BUY
Open market or private purchase
$10,089 $3.38 p/Share
2,985 Added 0.13%
2,305,837 Class A Common Stock
Jun 18 2025
BUY
Open market or private purchase
$50,190 $2.39 p/Share
21,000 Added 0.9%
2,302,852 Class A Common Stock
Mar 19 2024
BUY
Open market or private purchase
$55,400 $2.77 p/Share
20,000 Added 0.87%
2,281,852 Class A Common Stock
Dec 22 2022
BUY
Exercise of conversion of derivative security
$7,524 $3.01 p/Share
2,500 Added 0.11%
2,261,852 Class A Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
$6,020 $3.01 p/Share
2,000 Added 0.09%
2,259,352 Class A Common Stock
Mar 23 2022
BUY
Open market or private purchase
$24,060 $8.02 p/Share
3,000 Added 0.13%
2,257,352 Class A Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
$6,020 $3.01 p/Share
2,000 Added 0.09%
2,254,352 Class A Common Stock
Sep 13 2021
BUY
Open market or private purchase
$47,638 $22.87 p/Share
2,083 Added 0.08%
2,602,352 Class A Common Stock
Aug 03 2021
BUY
Open market or private purchase
$31,470 $15.0 p/Share
2,098 Added 0.08%
2,600,269 Class A Common Stock
Aug 03 2021
BUY
Conversion of derivative security
-
49,099 Added 1.85%
2,598,171 Class A Common Stock
BJZ

Benjamin J. Zeskind

PRESIDENT AND CEO
Cambridge, MA

Track Institutional and Insider Activities on IMRX

Follow Immuneering Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

News

Receive news related to Immuneering Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMRX